Skip to main content

Table 1.

Effects of 5-fluorouracil, Cyrtopodion scabrum homogenate, and Cyrtopodion scabrum extract on the averages of body weight and dietary and water intake on days 9 and 14 and weight of the livers on day 14th

Body weight (g) Food intake (g/day) Water intake (ml/day) Weight of the livers
Groups n Day 9 Day 14 Day 9 Day 14 Day 9 Day 14 Day 14th
Control 10 237.6±5.0 260.8±5.6 19.4±0.9 19.3±0.3 41.5±7.7 40.9±2.0 8.8±1.3
5-FU 9 236.9±5.4 224.1±3.7ab 19.2±1.4 3.3±4.2ab 44.0±8.2 10.8±8.3ab 6.7±0.8a
CsH 10 244.7±4.8 273.1±4.7 19.7±0.4 20.0±0.0 46.7±10.5 45.7±3.0 8.6±1.6
CsE 10 241.6±4.2 268.2±3.6 19.8±0.9 20.0±0.0 48.7±8.0 45.2±1.7 9.4±1.3
CsH+5-FU 10 245.7±6.6 248.4±6.7ab 19.5±1.3 6.8±2.5ab 44.4±12.7 19.6±4.1ab 6.6±1.1a
CsE+5-FU 9 244.3±4.7 245±4.5ab 19.6±1.3 7.9±2.7ab 44.1±9.8 18.7±3.3ab 7.2±0.9a

1. Data expressed as mean±standard error of the mean; in each column, figures bearing different letter superscripts significantly different at P<0.05 (Mann-Whitney U test and Wilcoxon test) (a: compared to control on day 14; b: compared to 5-fluorouracil group on day 14)

5-FU: 5-fluorouracil; CsH: Cyrtopodion scabrum homogenate; CsE: Cyrtopodion scabrum extract